Origin of cholesterol in myelin

Neurochemical Research

Volumn 21, Issue 4, 1996, Pages 463-470

  Morell, Pierre ^a,b   Jurevics, Helga ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Cholesterol; development; myelination; nervous system

Indexed keywords

CHOLESTEROL; STEROL; TRITIUM OXIDE;

ARTICLE; BIOACCUMULATION; BODY WATER; BRAIN DEVELOPMENT; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CHOLESTEROL TRANSPORT; MYELINATION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; RADIOACTIVITY;

ANIMALS; BODY WATER; BRAIN; CHOLESTEROL; HUMANS; KIDNEY; KINETICS; MYELIN SHEATH; PERIPHERAL NERVOUS SYSTEM; RESEARCH DESIGN; TRITIUM;

TRITIUM;

EID: 0029942903     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02527711     Document Type: Article

References (31)

1. Dietschy, J. M., and Spady, D. K. 1984. Measurement of rates of cholesterol synthesis using tritiated water. J. Lipid Res. 25:1469-1476.
2. Morell, P., Quarles, R. H., and Norton, W. T. 1993. Myelin formation, structure, and biochemistry. Pages 117-143, in Albers, R. W., Siegel, G. W., Molinoff, P., and Agranoff, B. (eds.), Basic Neurochemistry. 5th Edition. Raven Press, New York.
3. Haque, Z. U., and Mozaffor, Z. 1992. Importance of dietary cholesterol for the maturation of mouse brain myelin. Biosci. Biotech. Biochem. 56:1351-1354.
4. Acosta, P. B. 1994. RSH/SLO (Smith-Lemli-Opitz) syndrome: Designing a high cholesterol diet for the SLO syndrome. Am. J. of Med. Genet. 50:358-363.
5. Smith, M. E. 1987. The metabolism of myelin lipids. Adv. in Lipid Res. 5:241-278.
6. Waelsch, H., Sperry, W. M., and Stoyanoff, V. A. 1941. The influence of growth and demyelination on the deposition and metabolism of lipids in the brain. J. Biol. Chem. 140:885-897.
7. Davison, A. N. 1965. Brain sterol metabolism. Adv. Lipid Res. 3: 171-196.
8. Smith, M. E. 1973. A regional survey of myelin development: some compositional and metabolic aspects. J. Lipid Res. 14:541-551.
9. Rawlins, F. A., and Smith, M. E. 1971. Myelin synthesis in vitro: A comparative study of central and peripheral nervous tissue. J. Neurochem. 18:1861-1870.
10. Smith, M. E., and Eng, L. F. 1965. The turnover of the lipid components of myelin. J. of the Am. Oil Chemists' Soc. 42:1013-1018.
11. 14C) cholesterol in the brain of growing chickens. J. Neurochem. 3:89-94.
12. 14C in the central nervous system. Nature (London) 183:1606-1607.
13. Kritchevsky, D., and Defendi, V. 1962. Deposition of tritium labelled sterols (cholesterol, sitosterol, lanosterol) in brain and other organs of the growing chicken. J. Neurochem. 9:421-425.
14. Dobbing, J. 1963. The entry of cholesterol into rat brain during development. J. Neurochem. 10:739-742.
15. Edmond, J., Korsak, R. A., Morrow, J. W., Torok-Both, G., and Catlin, D. H. 1991. Dietary cholesterol and the origin of cholesterol in the brain of developing rats. J. Nutr. 121:1323-1330.
16. 14C labeled substrates. J. Lipid Res. 20:740-752.
17. Jurevics, H. A., and Morell, P. 1994. Sources of cholesterol for kidney and nerve during development. J. Lipid Res. 35:112-120.
18. Jurevics, H., and Morell, P. 1995. Cholesterol for synthesis of myelin is made locally, not imported into brain. J. Neurochem. 64:895-901.
19. Wagner-Recio M., Toews, A. D., and Morell, P. 1991. Tellurium blocks cholesterol synthesis by inhibiting squalene metabolism: Preferential vulnerability to this metabolic block leads to peripheral nervous system demyelination. J. Neurochem. 57:1891-1901.
20. Toews, A. D., Goodrum, J. F., Lee, S. Y., Eckermann, C., and Morell, P. 1991. Tellurium-induced alterations in HMG-CoA reductase gene expression and enzyme activity: Differential effects in sciatic nerve and liver suggest tissue-specific regulation of cholesterol synthesis. J. Neurochem. 57:1902-1906.
21. Irons, M., Elias, E. R., Salen, G., Tint, G. S., and Batta, A. K. 1993. Defective cholesterol biosynthesis in Smith-Lemli-Opitz syndrome. Lancet 341:1414.
22. Tint, G. S., Irons, M., Elias, E. R., Batta, A. K., Frieden, R., Chen, T. S., and Salen, G. S. 1994. Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. New Eng. J. of Med. 330:107-113.
23. Barness, L. A. 1994. Nutritional requirements of infants and children with respect to cholesterol and related compounds. Am. J. of Med. Genet. 50:353-354.
24. Irons, M., Elias, E. R., Tint, G. S., Salen, G., Frieden, R., Buie, T. M., and Ampola, M. 1994. Abnormal cholesterol metabolism in the Smith-Lemli-Opitz syndrome: Report of clinical and biochemical findings in four patients and treatment in one patient. Am. J. of Med. Genet. 50:347-352.
25. Nwokoro, N. A., Hyde, B., and Mulvihill, J. J. 1994. Smith-Lemli-Opitz Syndrome: Biochemical before clinical diagnosis; early dietary management. Am. Jour. of Med. Genet. 50:375-376.
26. Smith, M. E., and Hasinoff, C. M. 1970. Inhibitors of cholesterol synthesis and myelin formation. Lipids 5:665-671.
27. Suzuki, K., and DePaul, L. D. 1971. Cellular degeneration in developing central nervous system of rats produced by hypocholesteremic drug AY9944. Lab. Invest. 25:546-555.
28. Roux, C., Horvath, C., and Depuis, R. 1979. Teratogenic action and embryo lethality of AY9944: Prevention by a hypercholesterolemia-provoking diet. Teratology 19:35-38.
29. Barbu, V., Roux, C., Lambert, D., Duphis, R., Garderie, J., Maziere, J.-C., Maziere, C., Elefant, R., and Polonovski, J. 1988. Cholesterol prevents the teratogenic action of AY9944: Importance of the timing of cholesterol supplementation to rats. J. Nutr. 118:774-779.
30. Xu, G., Salen, G., Shefer, S., Ness, G. C., Chen, T. S., Zhao, Z., and Tint, G. S. 1995. Reproducing abnormal cholesterol biosynthesis as seen in the Smith-Lemli-Opitz syndrome by inhibiting the conversion of 7-dehydrocholesterol to cholesterol in rats. J. Clin. Invest. 95:76-81.
31. Lakshmanan, M. R., and Veech, R. L. 1977. Measurement of rate of rat liver sterol synthesis in vivo using tritiated water. J. Biol. Chem. 252:4667-4673.